miR-520h is crucial for DAPK2 regulation and breast cancer progression

Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers

(2013) V. Gordon et al.   CLINICAL CANCER RESEARCH

Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance

(2012) Takenori Ogawa et al.   CELL CYCLE

MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol

(2012) Y-H Yu et al.   ONCOGENE

miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans

(2011) Pai-Sheng Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer

(2011) J. Baselga   ONCOLOGIST

MicroRNA-mediated drug resistance in breast cancer

(2011) Kristy R. Kutanzi et al.   Clinical Epigenetics

Downregulation of MicroRNA miR-520h by E1A Contributes to Anticancer Activity

(2010) Jen-Liang Su et al.   CANCER RESEARCH

MicroRNAs in Cancer

(2009) Ramiro Garzon et al.   Annual Review of Medicine

Role of microRNA in anticancer drug resistance

(2009) Tongsen Zheng et al.   INTERNATIONAL JOURNAL OF CANCER

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

(2009) K. K.W. To et al.   MOLECULAR CANCER THERAPEUTICS

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

(2008) O. Kovalchuk et al.   MOLECULAR CANCER THERAPEUTICS